Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Menu dropdown menu Search search

Eyewire News

Featured Story

FDA Approves Genentech's Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease image

10.16.2026

FDA Approves Genentech's Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease

Latest News Stories

10.16.2026

Alvotech and Advanz Pharma Submit European Application for First Proposed Eylea 8 mg Biosimilar
International Eye Health Organizations Call for Global Support of St John's Compact Ahead of 2026 Summit image

10.16.2026

International Eye Health Organizations Call for Global Support of St John's Compact Ahead of 2026 Summit

10.15.2026

Study Finds Rising Demand for Emergency Ophthalmology Consultations Across US Academic Centers
Raytracing-Guided LASIK Improves Visual Outcomes in Patients Dissatisfied after Cataract Surgery image

10.15.2026

Raytracing-Guided LASIK Improves Visual Outcomes in Patients Dissatisfied after Cataract Surgery
Eclipse Life Sciences Reports Positive Phase 2 Results for EC-104 in DME image

10.15.2026

Eclipse Life Sciences Reports Positive Phase 2 Results for EC-104 in DME
European Trial Finds PRIMA Retinal Implant Demonstrates Sustained Vision Improvement at 3 Years in GA image

10.14.2026

European Trial Finds PRIMA Retinal Implant Demonstrates Sustained Vision Improvement at 3 Years in GA
Cosmetic Products Linked to More than 42,000 Eye Injuries Over 20 Years, Study Finds image

10.14.2026

Cosmetic Products Linked to More than 42,000 Eye Injuries Over 20 Years, Study Finds
Euclid Vision Launches My Euclid Platform to Streamline Orthokeratology Fitting and Ordering image

10.14.2026

Euclid Vision Launches My Euclid Platform to Streamline Orthokeratology Fitting and Ordering

10.12.2026

ANI Pharmaceuticals Reports Sustained 24-Month Efficacy of Iluvien in Phase 4 SYNCHRONICITY Trial

10.12.2026

Merck’s Remigromig Meets Primary Endpoint in Phase 2b/3 BRUNELLO Trial for DME
Stoke Therapeutics Presents STK-002 Data for Autosomal Dominant Optic Atrophy at AAO image

10.12.2026

Stoke Therapeutics Presents STK-002 Data for Autosomal Dominant Optic Atrophy at AAO
American Academy of Ophthalmology Announces 2026 Award Recipients at Annual Conference image

10.12.2026

American Academy of Ophthalmology Announces 2026 Award Recipients at Annual Conference
Lumenis Launches Ocular Surface Disease Field Guide for Cataract and Refractive Surgeons at AAO image

10.12.2026

Lumenis Launches Ocular Surface Disease Field Guide for Cataract and Refractive Surgeons at AAO
Brent Saunders Departs as CEO of Bausch + Lomb image

10.12.2026

Brent Saunders Departs as CEO of Bausch + Lomb

10.11.2026

Claris Biotherapeutics Reports Positive Phase 2 Data for CSB-001 in Limbal Stem Cell Deficiency
Glaukos Reports Positive Phase 4 Results for iDose TR Combined with Cataract Surgery image

10.09.2026

Glaukos Reports Positive Phase 4 Results for iDose TR Combined with Cataract Surgery
Perceive Bio Completes Phase 2a Enrollment in VOY-101 Gene Therapy Study for Geographic Atrophy image

10.09.2026

Perceive Bio Completes Phase 2a Enrollment in VOY-101 Gene Therapy Study for Geographic Atrophy

10.09.2026

BioTissue to Present Phase 2 TTAX03 Dry Eye Disease Study Results at AAO

10.09.2026

Carrot to Acquire GreenMan Vision, Expanding VR Platform into IOL Simulation for Cataract Surgery

View More

EyewireTV

Eyewire TV October 14, 2026 thumbnail

Stay Updated

Sign up for Eyewire News and EyewireTV e‑newsletters to stay up to date on news in eye care!

Subscribe right arrow